Cardiac stem cell therapy: Stemness or commitment?

Cell Transplantation

Volumn 22, Issue 1, 2013, Pages 1-14

  Mehta, Ashish ^a   Shim, Winston ^a  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Cardiomyocytes; Differentiation; Myocardial infarction; Regenerative medicine; Stem cells

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; 5 AZA 2' DEOXYCYTIDINE; ACTIVIN A; ALPHA ACTININ; ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 4; CONNECTIN; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; INSULIN; INTERLEUKIN 6; MYOCYTE ENHANCER FACTOR 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RETINOIC ACID; SOMATOMEDIN C; THROMBIN; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; TROPOMYOSIN; TROPONIN I; VASCULAR CELL ADHESION MOLECULE 1;

BLASTOCYST; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL FATE; CELL REGENERATION; CONGESTIVE HEART FAILURE; ELECTROMAGNETIC RADIATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HEART FUNCTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; OUTCOME ASSESSMENT; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIDE POPULATION CELL; STEM CELL TRANSPLANTATION; STROMA CELL; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; HEART DISEASES; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION;

EID: 84873028045     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X653282     Document Type: Review

References (134)

1. Abdel-Latif, A.; Bolli, R.; Tleyjeh, I. M.; Montori, V. M.; Perin, E. C.; Hornung, C. A.; Zuba-Surma, E. K.; Al-Mallah, M.; Dawn, B. Adult bone marrow-derived cells for cardiac repair: A systematic review and metaanalysis. Arch. Intern. Med. 167(10):989-997; 2007.
2. Ahuja, P.; Sdek, P.; MacLellan, W. R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87(2):521-544; 2007.
3. Alvarez-Dolado, M.; Pardal, R.; Garcia-Verdugo, J. M.; Fike, J. R.; Lee, H. O.; Pfeffer, K.; Lois, C.; Morrison, S. J.; Alvarez-Buylla, A. Fusion of bone marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961):968-973; 2003.
4. Anderson, D.; Self, T.; Mellor, I. R.; Goh, G.; Hill, S. J.; Denning, C. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol. Ther. 15(11):2027-2036; 2007.
5. Antonitsis, P.; Ioannidou-Papagiannaki, E.; Kaidoglou, A.; Papakonstantinou, C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact. Cardiovasc. Thorac. Surg. 6(5):593-597; 2007.
6. Ballard, V. L.; Edelberg, J. M. Stem cells and the regeneration of the aging cardiovascular system. Circ. Res. 100(8):1116-1127; 2007.
7. Balsam, L. B.; Wagers, A. J.; Christensen, J. L.; Kofidis, T.; Weissman, I. L.; Robbins, R. C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983):668-673; 2004.
8. Behfar, A.; Yamada, S.; Crespo-Diaz, R.; Nesbitt, J. J.; Rowe, L. A.; Perez-Terzic, C.; Gaussin, V.; Homsy, C.; Bartunek, J.; Terzic, A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56(9):721-734; 2010.
9. Beltrami, A. P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6):763-776; 2003.
10. Bittner, R. E.; Schofer, C.; Weipoltshammer, K.; Ivanova, S.; Streubel, B.; Hauser, E.; Freilinger, M.; Hoger, H.; Elbe-Burger, A.; Wachtler, F. Recruitment of bone marrowderived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. 199(5):391-396; 1999.
11. Blin, G.; Nury, D.; Stefanovic, S.; Neri, T.; Guillevic, O.; Brinon, B.; Bellamy, V.; Rucker-Martin, C.; Barbry, P.; Bel, A.; Bruneval, P.; Cowan, C.; Pouly, J.; Mitalipov, S.; Gouadon, E.; Binder, P.; Hagege, A.; Desnos, M.; Renaud, J. F.; Menasche, P.; Puceat, M. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120(4):1125-1139; 2010.
12. Bolli, R.; Chugh, A. R.; D'Amario, D.; Loughran, J. H.; Stoddard, M. F.; Ikram, S.; Beache, G. M.; Wagner, S. G.; Leri, A.; Hosoda, T.; Sanada, F.; Elmore, J. B.; Goichberg, P.; Cappetta, D.; Solankhi, N. K.; Fahsah, I.; Rokosh, D. G.; Slaughter, M. S.; Kajstura, J.; Anversa, P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378(9806):1847-1857; 2011.
13. Breitbach, M.; Bostani, T.; Roell, W.; Xia, Y.; Dewald, O.; Nygren, J. M.; Fries, J. W.; Tiemann, K.; Bohlen, H.; Hescheler, J.; Welz, A.; Bloch, W.; Jacobsen, S. E.; Fleischmann, B. K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110(4):1362-1369; 2007.
14. Burridge, P. W.; Anderson, D.; Priddle, H.; Barbadillo Munoz, M. D.; Chamberlain, S.; Allegrucci, C.; Young, L. E.; Denning, C. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 25(4):929-938; 2007.
15. Cai, C. L.; Liang, X.; Shi, Y.; Chu, P. H.; Pfaff, S. L.; Chen, J.; Evans, S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5(6):877-889; 2003.
16. Carr, C. A.; Stuckey, D. J.; Tatton, L.; Tyler, D. J.; Hale, S. J.; Sweeney, D.; Schneider, J. E.; Martin-Rendon, E.; Radda, G. K.; Harding, S. E.; Watt, S. M.; Clarke, K. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: An in vivo cine-MRI study. Am. J. Physiol. Heart Circ. Physiol. 295(2):H533-H542; 2008.
17. Caspi, O.; Huber, I.; Kehat, I.; Habib, M.; Arbel, G.; Gepstein, A.; Yankelson, L.; Aronson, D.; Beyar, R.; Gepstein, L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50(19):1884-1893; 2007.
18. Chavakis, E.; Koyanagi, M.; Dimmeler, S. Enhancing the outcome of cell therapy for cardiac repair: Progress from bench to bedside and back. Circulation 121(2):325-335; 2010.
19. Chiu, R. C. Adult stem cell therapy for heart failure. Expert Opin. Biol. Ther. 3(2):215-225; 2003.
20. Christoforou, N.; Gearhart, J. D. Stem cells and their potential in cell-based cardiac therapies. Prog. Cardiovasc. Dis. 49(6):396-413; 2007.
21. Dambrot, C.; Passier, R.; Atsma, D.; Mummery, C. L. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem. J. 434(1):25-35; 2011.
22. Dawn, B.; Tiwari, S.; Kucia, M. J.; Zuba-Surma, E. K.; Guo, Y.; Sanganalmath, S. K.; Abdel-Latif, A.; Hunt, G.; Vincent, R. J.; Taher, H.; Reed, N. J.; Ratajczak, M. Z.; Bolli, R. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells 26(6):1646-1655; 2008.
23. Denning, C.; Allegrucci, C.; Priddle, H.; Barbadillo-Munoz, M. D.; Anderson, D.; Self, T.; Smith, N. M.; Parkin, C. T.; Young, L. E. Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int. J. Dev. Biol. 50(1):27-37; 2006.
24. Dimmeler, S.; Burchfield, J.; Zeiher, A. M. Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28(2):208-216; 2008.
25. Doetschman, T. C.; Eistetter, H.; Katz, M.; Schmidt, W.; Kemler, R. The in vitro development of blastocystderived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27-45; 1985.
26. Dubois, N. C.; Craft, A. M.; Sharma, P.; Elliott, D. A.; Stanley, E. G.; Elefanty, A. G.; Gramolini, A.; Keller, G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 29(11):1011-1018; 2011.
27. Elliott, D. A.; Braam, S. R.; Koutsis, K.; Ng, E. S.; Jenny, R.; Lagerqvist, E. L.; Biben, C.; Hatzistavrou, T.; Hirst, C. E.; Yu, Q. C.; Skelton, R. J.; Ward-van Oostwaard, D.; Lim, S. M.; Khammy, O.; Li, X.; Hawes, S. M.; Davis, R. P.; Goulburn, A. L.; Passier, R.; Prall, O. W.; Haynes, J. M.; Pouton, C. W.; Kaye, D. M.; Mummery, C. L.; Elefanty, A. G.; Stanley, E. G. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8(12):1037-1040; 2011.
28. Engler, A. J.; Sen, S.; Sweeney, H. L.; Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126(4):677-689; 2006.
29. Fernandes, S.; Naumova, A. V.; Zhu, W. Z.; Laflamme, M. A.; Gold, J.; Murry, C. E. Human embryonic stem cellderived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J. Mol. Cell. Cardiol. 49(6):941-949; 2010.
30. Fernandez-Aviles, F.; San Roman, J. A.; Garcia-Frade, J.; Fernandez, M. E.; Penarrubia, M. J.; de la Fuente, L.; Gomez-Bueno, M.; Cantalapiedra, A.; Fernandez, J.; Gutierrez, O.; Sanchez, P. L.; Hernandez, C.; Sanz, R.; Garcia-Sancho, J.; Sanchez, A. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95(7):742-748; 2004.
31. Freund, C.; Mummery, C. L. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J. Cell. Biochem. 107(4):592-599; 2009.
32. Fullilove, S. L. Heart induction: Distribution of active factors in newt endoderm. J. Exp. Zool. 175(3):323-326; 1970.
33. Gai, H.; Leung, E. L.; Costantino, P. D.; Aguila, J. R.; Nguyen, D. M.; Fink, L. M.; Ward, D. C.; Ma, Y. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol. Int. 33(11):1184-1193; 2009.
34. Gaur, M.; Ritner, C.; Sievers, R.; Pedersen, A.; Prasad, M.; Bernstein, H. S.; Yeghiazarians, Y. Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy 12(6):807-817; 2010.
35. Genovese, J. A.; Spadaccio, C.; Chachques, E.; Schussler, O.; Carpentier, A.; Chachques, J. C.; Patel, A. N. Cardiac predifferentiation of human mesenchymal stem cells by electrostimulation. Front. Biosci. 14:2996-3002; 2009.
36. Ghostine, S.; Carrion, C.; Souza, L. C.; Richard, P.; Bruneval, P.; Vilquin, J. T.; Pouzet, B.; Schwartz, K.; Menasche, P.; Hagege, A. A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106(12 Suppl 1):I131-136; 2002.
37. Gore, A.; Li, Z.; Fung, H. L.; Young, J. E.; Agarwal, S.; Antosiewicz-Bourget, J.; Canto, I.; Giorgetti, A.; Israel, M. A.; Kiskinis, E.; Lee, J. H.; Loh, Y. H.; Manos, P. D.; Montserrat, N.; Panopoulos, A. D.; Ruiz, S.; Wilbert, M. L.; Yu, J.; Kirkness, E. F.; Izpisua Belmonte, J. C.; Rossi, D. J.; Thomson, J. A.; Eggan, K.; Daley, G. Q.; Goldstein, L. S.; Zhang, K. Somatic coding mutations in human induced pluripotent stem cells. Nature 471(7336):63-67; 2011.
38. Graichen, R.; Xu, X.; Braam, S. R.; Balakrishnan, T.; Norfiza, S.; Sieh, S.; Soo, S. Y.; Tham, S. C.; Mummery, C.; Colman, A.; Zweigerdt, R.; Davidson, B. P. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76(4):357-370; 2008.
39. Hansson, E. M.; Lindsay, M. E.; Chien, K. R. Regeneration next: Toward heart stem cell therapeutics. Cell Stem Cell 5(4):364-377; 2009.
40. Hattori, F.; Chen, H.; Yamashita, H.; Tohyama, S.; Satoh, Y. S.; Yuasa, S.; Li, W.; Yamakawa, H.; Tanaka, T.; Onitsuka, T.; Shimoji, K.; Ohno, Y.; Egashira, T.; Kaneda, R.; Murata, M.; Hidaka, K.; Morisaki, T.; Sasaki, E.; Suzuki, T.; Sano, M.; Makino, S.; Oikawa, S.; Fukuda, K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 7(1):61-66; 2010.
41. He, J. Q.; Ma, Y.; Lee, Y.; Thomson, J. A.; Kamp, T. J. Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ. Res. 93(1):32-39; 2003.
42. Heng, B. C.; Haider, H.; Sim, E. K.; Cao, T.; Ng, S. C. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc. Res. 62(1):34-42; 2004.
43. Hu, X.; Wang, J.; Chen, J.; Luo, R.; He, A.; Xie, X.; Li, J. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur. J. Cardiothorac. Surg. 31(3):438-443; 2007.
44. Huber, I.; Itzhaki, I.; Caspi, O.; Arbel, G.; Tzukerman, M.; Gepstein, A.; Habib, M.; Yankelson, L.; Kehat, I.; Gepstein, L. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21(10):2551-2563; 2007.
45. Ieda, M.; Fu, J. D.; Delgado-Olguin, P.; Vedantham, V.; Hayashi, Y.; Bruneau, B. G.; Srivastava, D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375-386; 2010.
46. Jackson, K. A.; Majka, S. M.; Wang, H.; Pocius, J.; Hartley, C. J.; Majesky, M. W.; Entman, M. L.; Michael, L. H.; Hirschi, K. K.; Goodell, M. A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107(11):1395-1402; 2001.
47. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-49; 2002.
48. Kehat, I.; Gepstein, A.; Spira, A.; Itskovitz-Eldor, J.; Gepstein, L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: A novel in vitro model for the study of conduction. Circ. Res. 91(8):659-661; 2002.
49. Kehat, I.; Kenyagin-Karsenti, D.; Snir, M.; Segev, H.; Amit, M.; Gepstein, A.; Livne, E.; Binah, O.; Itskovitz-Eldor, J.; Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108(3):407-414; 2001.
50. Kehat, I.; Khimovich, L.; Caspi, O.; Gepstein, A.; Shofti, R.; Arbel, G.; Huber, I.; Satin, J.; Itskovitz-Eldor, J.; Gepstein, L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22(10):1282-1289; 2004.
51. Kim, Y. Y.; Ku, S. Y.; Jang, J.; Oh, S. K.; Kim, H. S.; Kim, S. H.; Choi, Y. M.; Moon, S. Y. Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2. Yonsei. Med. J. 49(5):819-827; 2008.
52. Klug, M. G.; Soonpaa, M. H.; Koh, G. Y.; Field, L. J. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 98(1):216-224; 1996.
53. Kurdi, M.; Booz, G. W. G-CSF-based stem cell therapy for the heart-unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering. Congest. Heart Fail. 13(6):347-351; 2007.
54. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L.; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25(9):1015-1024; 2007.
55. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026):647-653; 2005.
56. Lee, Y. K.; Ng, K. M.; Lai, W. H.; Chan, Y. C.; Lau, Y. M.; Lian, Q.; Tse, H. F.; Siu, C. W. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev. 7(4):976-986; 2011.
57. Leone, A. M.; Valgimigli, M.; Giannico, M. B.; Zaccone, V.; Perfetti, M.; D'Amario, D.; Rebuzzi, A. G.; Crea, F. From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells. Eur. Heart J. 30(8):890-899; 2009.
58. Leor, J.; Gerecht, S.; Cohen, S.; Miller, L.; Holbova, R.; Ziskind, A.; Shachar, M.; Feinberg, M. S.; Guetta, E.; Itskovitz-Eldor, J. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93(10):1278-1284; 2007.
59. Li, R. K.; Jia, Z. Q.; Weisel, R. D.; Mickle, D. A.; Zhang, J.; Mohabeer, M. K.; Rao, V.; Ivanov, J. Cardiomyocyte transplantation improves heart function. Ann. Thorac. Surg. 62(3):654-660; discussion 660-661; 1996.
60. Li, R. K.; Mickle, D. A.; Weisel, R. D.; Rao, V.; Jia, Z. Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann. Thorac. Surg. 72(6):1957-1963; 2001.
61. Li, X. H.; Fu, Y. H.; Lin, Q. X.; Liu, Z. Y.; Shan, Z. X.; Deng, C. Y.; Zhu, J. N.; Yang, M.; Lin, S. G.; Li, Y.; Yu, X. Y. Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts. Mol. Biol. Rep. 39(2):1333-1342; 2012.
62. Liao, R.; Pfister, O.; Jain, M.; Mouquet, F. The bone marrow-cardiac axis of myocardial regeneration. Prog. Cardiovasc. Dis. 50(1):18-30; 2007.
63. Liao, S. Y.; Liu, Y.; Siu, C. W.; Zhang, Y.; Lai, W. H.; Au, K. W.; Lee, Y. K.; Chan, Y. C.; Yip, P. M.; Wu, E. X.; Wu, Y.; Lau, C. P.; Li, R. A.; Tse, H. F. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7(12):1852-1859; 2010.
64. Lipinski, M. J.; Biondi-Zoccai, G. G.; Abbate, A.; Khianey, R.; Sheiban, I.; Bartunek, J.; Vanderheyden, M.; Kim, H. S.; Kang, H. J.; Strauer, B. E.; Vetrovec, G. W. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 50(18):1761-1767; 2007.
65. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5):697-705; 1999.
66. Malliaras, K.; Kreke, M.; Marban, E. The stuttering progress of cell therapy for heart disease. Clin. Pharmacol. Ther. 90(4):532-541; 2011.
67. Martin-Puig, S.; Wang, Z.; Chien, K. R. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2(4):320-331; 2008.
68. Mauritz, C.; Martens, A.; Rojas, S. V.; Schnick, T.; Rathert, C.; Schecker, N.; Menke, S.; Glage, S.; Zweigerdt, R.; Haverich, A.; Martin, U.; Kutschka, I. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 32(21):2634-2641; 2011.
69. Mehta, A.; Chung, Y. Y.; Ng, A.; Iskandar, F.; Atan, S.; Wei, H.; Dusting, G.; Sun, W.; Wong, P.; Shim, W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc. Res. 91(4):577-586; 2011.
70. Menasche, P. Stem cell therapy for chronic heart failure. Lessons from a 15-year experience. C. R. Biol. 334(7):489-496; 2011.
71. Menasche, P.; Alfieri, O.; Janssens, S.; McKenna, W.; Reichenspurner, H.; Trinquart, L.; Vilquin, J. T.; Marolleau, J. P.; Seymour, B.; Larghero, J.; Lake, S.; Chatellier, G.; Solomon, S.; Desnos, M.; Hagege, A. A. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 117(9):1189-1200; 2008.
72. Messina, E.; De Angelis, L.; Frati, G.; Morrone, S.; Chimenti, S.; Fiordaliso, F.; Salio, M.; Battaglia, M.; Latronico, M. V.; Coletta, M.; Vivarelli, E.; Frati, L.; Cossu, G.; Giacomello, A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95(9):911-921; 2004.
73. Mohr, J. C.; Zhang, J.; Azarin, S. M.; Soerens, A. G.; de Pablo, J. J.; Thomson, J. A.; Lyons, G. E.; Palecek, S. P.; Kamp, T. J. The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials 31(7):1885-1893; 2010.
74. + cardiovascular progenitors. FASEB J. 24(3):700-711; 2010.
75. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127(6):1151-1165; 2006.
76. Muller-Ehmsen, J.; Whittaker, P.; Kloner, R. A.; Dow, J. S.; Sakoda, T.; Long, T. I.; Laird, P. W.; Kedes, L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34(2):107-116; 2002.
77. Mummery, C.; Ward-van Oostwaard, D.; Doevendans, P.; Spijker, R.; van den Brink, S.; Hassink, R.; van der Heyden, M.; Opthof, T.; Pera, M.; de la Riviere, A. B.; Passier, R.; Tertoolen, L. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107(21):2733-2740; 2003.
78. Mummery, C. L.; van Achterberg, T. A.; van den Eijndenvan Raaij, A. J.; van Haaster, L.; Willemse, A.; de Laat, S. W.; Piersma, A. H. Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells. Differentiation 46(1):51-60; 1991.
79. Murry, C. E.; Soonpaa, M. H.; Reinecke, H.; Nakajima, H.; Nakajima, H. O.; Rubart, M.; Pasumarthi, K. B.; Virag, J. I.; Bartelmez, S. H.; Poppa, V.; Bradford, G.; Dowell, J. D.; Williams, D. A.; Field, L. J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983):664-668; 2004.
80. Nygren, J. M.; Jovinge, S.; Breitbach, M.; Sawen, P.; Roll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B. K.; Jacobsen, S. E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5):494-501; 2004.
81. Oh, H.; Bradfute, S. B.; Gallardo, T. D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L. H.; Behringer, R. R.; Garry, D. J.; Entman, M. L.; Schneider, M. D. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100(21):12313-12318; 2003.
82. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829):701-705; 2001.
83. Peran, M.; Marchal, J. A.; Lopez, E.; Jimenez-Navarro, M.; Boulaiz, H.; Rodriguez-Serrano, F.; Carrillo, E.; Sanchez-Espin, G.; de Teresa, E.; Tosh, D.; Aranega, A. Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy 12(3):332-337; 2010.
84. Potapova, I. A.; Doronin, S. V.; Kelly, D. J.; Rosen, A. B.; Schuldt, A. J.; Lu, Z.; Kochupura, P. V.; Robinson, R. B.; Rosen, M. R.; Brink, P. R.; Gaudette, G. R.; Cohen, I. S. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am. J. Physiol. Heart Circ. Physiol. 295(6):H2257-H2263; 2008.
85. Pozzobon, M.; Bollini, S.; Iop, L.; De Gaspari, P.; Chiavegato, A.; Rossi, C. A.; Giuliani, S.; Fascetti Leon, F.; Elvassore, N.; Sartore, S.; De Coppi, P. Human bone marrow-derived CD133(+) cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis. Cell Transplant. 19(10):1247-1260; 2010.
86. Qian, Q.; Qian, H.; Zhang, X.; Zhu, W.; Yan, Y.; Ye, S.; Peng, X.; Li, W.; Xu, Z.; Sun, L.; Xu, W. 5-Azacytidine induces cardiac differentiation of human umbilical cordderived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev. 21(1):67-75; 2012.
87. Rebelatto, C. K.; Aguiar, A. M.; Senegaglia, A. C.; Aita, C. M.; Hansen, P.; Barchiki, F.; Kuligovski, C.; Olandoski, M.; Moutinho, J. A.; Dallagiovanna, B.; Goldenberg, S.; Brofman, P. S.; Nakao, L. S.; Correa, A. Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochem. Biophys. Res. Commun. 378(3):456-461; 2009.
88. Reffelmann, T.; Konemann, S.; Kloner, R. A. Promise of blood-and bone marrow-derived stem cell transplantation for functional cardiac repair: Putting it in perspective with existing therapy. J. Am. Coll. Cardiol. 53(4):305-308; 2009.
89. Reinecke, H.; Poppa, V.; Murry, C. E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34(2):241-249; 2002.
90. Reyes, M.; Dudek, A.; Jahagirdar, B.; Koodie, L.; Marker, P. H.; Verfaillie, C. M. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109(3):337-346; 2002.
91. Rosca, A. M.; Burlacu, A. Effect of 5-azacytidine: Evidence for alteration of the multipotent ability of mesenchymal stem cells. Stem Cells Dev. 20(7):1213-1221; 2011.
92. Rubart, M.; Pasumarthi, K. B.; Nakajima, H.; Soonpaa, M. H.; Nakajima, H. O.; Field, L. J. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92(11):1217-1224; 2003.
93. Rubart, M.; Soonpaa, M. H.; Nakajima, H.; Field, L. J. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J. Clin. Invest. 114(6):775-783; 2004.
94. Sakai, T.; Li, R. K.; Weisel, R. D.; Mickle, D. A.; Jia, Z. Q.; Tomita, S.; Kim, E. J.; Yau, T. M. Fetal cell transplantation: A comparison of three cell types. J. Thorac. Cardiovasc. Surg. 118(4):715-724; 1999.
95. Schittini, A. V.; Celedon, P. F.; Stimamiglio, M. A.; Krieger, M.; Hansen, P.; da Costa, F. D.; Goldenberg, S.; Dallagiovanna, B.; Correa, A. Human cardiac explant-conditioned medium: Soluble factors and cardiomyogenic effect on mesenchymal stem cells. Exp. Biol. Med. 235(8):1015-1024; 2010.
96. Scorsin, M.; Hagege, A. A.; Marotte, F.; Mirochnik, N.; Copin, H.; Barnoux, M.; Sabri, A.; Samuel, J. L.; Rappaport, L.; Menasche, P. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 96(9 Suppl):II188-II193; 1997.
97. Shiba, Y.; Hauch, K. D.; Laflamme, M. A. Cardiac applications for human pluripotent stem cells. Curr. Pharm. Des. 15(24):2791-2806; 2009.
98. Shim, W.; Mehta, A.; Lim, S. Y.; Zhang, G.; Lim, C. H.; Chua, T.; Wong, P. G-CSF for stem cell therapy in acute myocardial infarction: Friend or foe? Cardiovasc. Res. 89(1):20-30; 2011.
99. Shim, W. S.; Jiang, S.; Wong, P.; Tan, J.; Chua, Y. L.; Tan, Y. S.; Sin, Y. K.; Lim, C. H.; Chua, T.; Teh, M.; Liu, T. C.; Sim, E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun. 324(2):481-488; 2004.
100. Shim, W. S.; Tan, G.; Gu, Y.; Qian, L.; Li, S.; Chung, Y. Y.; Lim, S. Y.; Sim, E.; Chuah, S. C.; Wong, P. Dosedependent systolic contribution of differentiated stem cells in post-infarct ventricular function. J. Heart. Lung. Transplant. 29(12):1415-1426; 2010.
101. Shinmura, D.; Togashi, I.; Miyoshi, S.; Nishiyama, N.; Hida, N.; Tsuji, H.; Tsuruta, H.; Segawa, K.; Tsukada, Y.; Ogawa, S.; Umezawa, A. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells 29(2):357-366; 2011.
102. Shiota, M.; Heike, T.; Haruyama, M.; Baba, S.; Tsuchiya, A.; Fujino, H.; Kobayashi, H.; Kato, T.; Umeda, K.; Yoshimoto, M.; Nakahata, T. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp. Cell Res. 313(5):1008-1023; 2007.
103. Smits, A. M.; van Laake, L. W.; den Ouden, K.; Schreurs, C.; Szuhai, K.; van Echteld, C. J.; Mummery, C. L.; Doevendans, P. A.; Goumans, M. J. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 83(3):527-535; 2009.
104. Smits, A. M.; van Vliet, P.; Metz, C. H.; Korfage, T.; Sluijter, J. P.; Doevendans, P. A.; Goumans, M. J. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: An in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protoc. 4(2):232-243; 2009.
105. Sohn, R. L.; Jain, M.; Liao, R. Adult stem cells and heart regeneration. Expert Rev. Cardiovasc. Ther. 5(3):507-517; 2007.
106. Sugi, Y.; Lough, J. Anterior endoderm is a specific effector of terminal cardiac myocyte differentiation of cells from the embryonic heart forming region. Dev. Dyn. 200(2):155-162; 1994.
107. Sun, Y.; Liang, X.; Najafi, N.; Cass, M.; Lin, L.; Cai, C. L.; Chen, J.; Evans, S. M. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev. Biol. 304(1):286-296; 2007.
108. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872; 2007.
109. Tallini, Y. N.; Greene, K. S.; Craven, M.; Spealman, A.; Breitbach, M.; Smith, J.; Fisher, P. J.; Steffey, M.; Hesse, M.; Doran, R. M.; Woods, A.; Singh, B.; Yen, A.; Fleischmann, B. K.; Kotlikoff, M. I. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc. Natl. Acad. Sci. USA 106(6):1808-1813; 2009.
110. Tan, G.; Shim, W.; Gu, Y.; Qian, L.; Chung, Y. Y.; Lim, S. Y.; Yong, P.; Sim, E.; Wong, P. Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation 79(4-5):260-271; 2010.
111. Tay, C. Y.; Yu, H.; Pal, M.; Leong, W. S.; Tan, N. S.; Ng, K. W.; Leong, D. T.; Tan, L. P. Micropatterned matrix directs differentiation of human mesenchymal stem cells towards myocardial lineage. Exp. Cell. Res. 316(7):1159-1168; 2010.
112. Taylor, R. G.; Koohmaraie, M. Effects of postmortem storage on the ultrastructure of the endomysium and myofibrils in normal and callipyge longissimus. J. Anim. Sci. 76(11):2811-2817; 1998.
113. Terada, N.; Hamazaki, T.; Oka, M.; Hoki, M.; Mastalerz, D. M.; Nakano, Y.; Meyer, E. M.; Morel, L.; Petersen, B. E.; Scott, E. W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416(6880):542-545; 2002.
114. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147; 1998.
115. Toma, C.; Pittenger, M. F.; Cahill, K. S.; Byrne, B. J.; Kessler, P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1):93-98; 2002.
116. Tomescot, A.; Leschik, J.; Bellamy, V.; Dubois, G.; Messas, E.; Bruneval, P.; Desnos, M.; Hagege, A. A.; Amit, M.; Itskovitz, J.; Menasche, P.; Puceat, M. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 25(9):2200-2205; 2007.
117. Tongers, J.; Losordo, D. W.; Landmesser, U. Stem and progenitor cell-based therapy in ischaemic heart disease: Promise, uncertainties, and challenges. Eur. Heart J. 32(10):1197-1206; 2011.
118. Tse, H. F.; Lau, C. P. Therapeutic angiogenesis with bone marrow-derived stem cells. J. Cardiovasc. Pharmacol. Ther. 12(2):89-97; 2007.
119. van Laake, L. W.; Passier, R.; Monshouwer-Kloots, J.; Verkleij, A. J.; Lips, D. J.; Freund, C.; den Ouden, K.; Ward-van Oostwaard, D.; Korving, J.; Tertoolen, L. G.; van Echteld, C. J.; Doevendans, P. A.; Mummery, C. L. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1(1):9-24; 2007.
120. Vieyra, D. S.; Jackson, K. A.; Goodell, M. A. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev. 1(1):65-69; 2005.
121. + very small embryonic-like stem cells in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 53(1):1-9; 2009.
122. Xu, C.; Police, S.; Hassanipour, M.; Gold, J. D. Cardiac bodies: A novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev. 15(5):631-639; 2006.
123. Xu, C.; Police, S.; Rao, N.; Carpenter, M. K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91(6):501-508; 2002.
124. Xue, T.; Cho, H. C.; Akar, F. G.; Tsang, S. Y.; Jones, S. P.; Marban, E.; Tomaselli, G. F.; Li, R. A. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers. Circulation 111(1):11-20; 2005.
125. + embryonic-stem-cell-derived population. Nature 453(7194):524-528; 2008.
126. Yao, M.; Dieterle, T.; Hale, S. L.; Dow, J. S.; Kedes, L. H.; Peterson, K. L.; Kloner, R. A. Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J. Mol. Cell. Cardiol. 35(6):661-670; 2003.
127. Yoon, Y. S.; Park, J. S.; Tkebuchava, T.; Luedeman, C.; Losordo, D. W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109(25):3154-3157; 2004.
128. Zeng, L.; Hu, Q.; Wang, X.; Mansoor, A.; Lee, J.; Feygin, J.; Zhang, G.; Suntharalingam, P.; Boozer, S.; Mhashilkar, A.; Panetta, C. J.; Swingen, C.; Deans, R.; From, A. H.; Bache, R. J.; Verfaillie, C. M.; Zhang, J. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115(14):1866-1875; 2007.
129. Zhang, J.; Wilson, G. F.; Soerens, A. G.; Koonce, C. H.; Yu, J.; Palecek, S. P.; Thomson, J. A.; Kamp, T. J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104(4):e30-e41; 2009.
130. Zhang, Q.; Jiang, J.; Han, P.; Yuan, Q.; Zhang, J.; Zhang, X.; Xu, Y.; Cao, H.; Meng, Q.; Chen, L.; Tian, T.; Wang, X.; Li, P.; Hescheler, J.; Ji, G.; Ma, Y. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 21(4):579-587; 2011.
131. Zhao, M.; Barron, M. R.; Li, Z.; Koprowski, S.; Hall, C. L.; Lough, J. Making stem cells infarct avid. Cell Transplant. 19(2):245-250; 2010.
132. Zhao, T.; Zhang, Z. N.; Rong, Z.; Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212-215; 2011.
133. Zhu, W. Z.; Xie, Y.; Moyes, K. W.; Gold, J. D.; Askari, B.; Laflamme, M. A. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 107(6):776-786; 2010.
134. Zimmermann, W. H.; Melnychenko, I.; Wasmeier, G.; Didie, M.; Naito, H.; Nixdorff, U.; Hess, A.; Budinsky, L.; Brune, K.; Michaelis, B.; Dhein, S.; Schwoerer, A.; Ehmke, H.; Eschenhagen, T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4):452-458; 2006.